Journavax was shown in clinical trials to be safe and effective, with no addictive potential. 

Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.

Nina Kottler, MD, associate CMO for clinical AI at Radiology Partners, explains the movement toward greater regulation of artificial intelligence and the need to test for bias. 

It is estimated that the demand for contrast-enhanced imaging could double over the next decade. 

A bipartisan bill designed to block recent Medicare payment cuts has been reintroduced to Congress after failing to pass in 2024. Will things be any different this time around? 

Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.

Last week’s blastoff of the Chinese AI company DeepSeek struck many like a cold bucket of water in the face.

Wasn’t radiology the fastest medical specialty to embrace and adopt AI? And yet burnout continues to afflict many if not most radiologists. 

The parts, training and support company DirectMed Imaging of San Diego is acquiring a majority of assets owned by Richardson Healthcare in LaFox, Ill. 

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025.